The tumor-killing ability of ITK-KO CD19-CAR-T cells was compared with that of control CD19-CAR-T cells that were electroporated with an RNP complex containing a nontargeting sgRNA (nt-KO). The gene discussed is CD19; the disease is neoplasm.